Evidence map›Paper›PMID 32304183›Full record

ArticleThe journal of pathology. Clinical research2020

Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.

Raymond Barnhill, Pieter-Jan van Dam, Peter Vermeulen, Gabriel Champenois, André Nicolas, Robert V Rawson, James S Wilmott, John F Thompson, Georgina V Long, Nathalie Cassoux and 5 more

Open access · goldAbstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Consideration on immunotherapy of liver metastases of malignant tumors.World journal of gastrointestinal surgery · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Raymond BarnhillDepartment of Pathology, Institut Curie, Paris, France.ORCID 0000-0001-8086-8544
Pieter-Jan van DamFaculty of Medicine and Health Sciences, University of Antwerp - MIPRO Center for Oncological Research (CORE) - TCRU, GZA Sint-Augustinus, Antwerpen, Belgium.
Peter VermeulenFaculty of Medicine and Health Sciences, University of Antwerp - MIPRO Center for Oncological Research (CORE) - TCRU, GZA Sint-Augustinus, Antwerpen, Belgium.
Gabriel ChampenoisExperimental Pathology, Department of Pathology, Institut Curie, Paris, France.
André NicolasExperimental Pathology, Department of Pathology, Institut Curie, Paris, France.
Robert V RawsonMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
James S WilmottMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
John F ThompsonMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Georgina V LongMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Nathalie CassouxFaculty of Medicine, University of Paris Réné Descartes, Paris, France.
Sergio Roman-RomanDepartment of Translational Research, Institut Curie, Paris, France.
Klaus J BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Alexander J LazarDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-4144-8824
Claire LugassyDepartment of Translational Research, Institut Curie, Paris, France.ORCID 0000-0003-4390-4360
The University of Sydney · AUInstitut Curie · FRDélégation Paris 5 · FRUniversity of Antwerp · BEMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Among visceral metastatic sites, cutaneous melanoma (CM) metastasises initially to the liver in ~14-20% of cases. Liver metastases in CM patients are associated with both poor prognosis and poor response to immunotherapy. Histopathological growth patterns (HGPs) of liver metastases of the replacement and desmoplastic type, particularly from colorectal cancer and uveal melanoma (UM), may impart valuable biological and prognostic information. Here, we have studied HGP in 43 CM liver metastases resected from 42 CM patients along with other prognostic factors from three institutions. The HGPs (replacement, desmoplastic, pushing) were scored at the metastasis-liver interface with two algorithms: (1) 100% desmoplastic growth pattern (dHGP) and any (≥1%) replacement pattern (any-rHGP) and (2) >50% dHGP, >50% rHGP or mixed (<50% dHGP and/or rHGP, pushing HGP). For 1 patient with 2 metastases, an average was taken to obtain 1 final HGP yielding 42 observations from 42 patients. 22 cases (52%) had 100% dHGP whereas 20 (48%) had any replacement. Cases with rHGP demonstrated vascular co-option/angiotropism. With the development of liver metastasis, only rHGP (both algorithms), male gender and positive resection margins predicted diminished overall survival (p = 0.00099 and p = 0.0015; p = 0.034 and p = 0.024 respectively). On multivariate analysis, only HGP remained significant. 7 of 42 (17%) patients were alive with disease and 21 (50%) died with follow-up after liver metastases ranging from 1.8 to 42.2 months (mean: 20.4 months, median: 19.0 months). 14 (33%) patients with previously-treated metastatic disease had no evidence of disease at last follow up. In conclusion, we report for the first time replacement and desmoplastic HGPs in CM liver metastases and their prognostic value, as in UM and other solid cancers. Of particular importance, any rHGP significantly predicted diminished overall survival while 100% dHGP correlated with increased survival. These results contribute to a better understanding of the biology of CM liver metastases and potentially may be utilised in managing patients with these metastases.

Indexed as

PrognosisAdultAgedCell ProliferationColorectal NeoplasmsCutaneous Malignant MelanomaFemaleHistocytochemistryHumansLiverLiver NeoplasmsMaleMelanomaMiddle AgedNeoplasms, Second PrimarySkin Neoplasmsangiotropismcutaneous melanomadesmoplasticextravascular migratory metastasishistopathological growth patternslivermetastasispericytic mimicryreplacementvascular co-option

Identifiers

PMID32304183
PMCPMC7339161
OpenAlexW3016341323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.